Avenir Corp reduced its position in Bank of America Co. (NYSE:BAC) by 1.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 757,627 shares of the financial services provider’s stock after selling 14,150 shares during the quarter. Bank of America accounts […]
Avenir Corp trimmed its stake in shares of The AES Co. (NYSE:AES – Free Report) by 1.3% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 1,641,933 shares of the utilities provider’s stock after selling 22,060 shares during the quarter. AES comprises about 3.0% of […]
Avenir Corp reduced its stake in Equinix, Inc. (NASDAQ:EQIX – Free Report) by 0.5% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,956 shares of the financial services provider’s stock after selling 15 shares during the period. Equinix accounts for about […]
Avenir Corp grew its stake in shares of Cytosorbents Co. (NASDAQ:CTSO – Free Report) by 6.4% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,719,732 shares of the medical research company’s stock after acquiring an additional 164,179 shares during the […]
Avenir Corp lowered its stake in shares of Vanguard S&P 500 ETF (NYSEARCA:VOO – Free Report) by 2.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,930 shares of the company’s stock after selling 53 shares during the period. […]